MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2023 International Congress

    Oculomotor parameters measured during free viewing of video differentiate Parkinson’s disease from progressive supranuclear palsy

    H. Riek, B. White, D. Brien, B. Coe, C. Fearon, S. Arnott, D. Beaton, M. Binns, S. Black, E. Finger, A. Frank, D. Grimes, A. Lang, W. Lou, C. Marras, M. Masellis, P. Mclaughlin, J. Orange, A. Peltsch, A. Roberts, T. Steeves, K. Sunderland, B. Tan, D. Tang-Wai, C. Tartaglia, D. Munoz (Kingston, Canada)

    Objective: Characterize oculomotor phenotypes comprised of saccade, pupil, and blink behaviour for progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) with differing degrees of cognitive…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study

    I. Straka, V. Bolekova, K. Cho, M. Jezberova, P. Brandoburova, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)

    Objective: The pilot study aimed to identify neuroanatomical predictors of cognitive performance in patients with iNPH. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a specific…
  • 2023 International Congress

    Unusual Neuronal Intranuclear Inclusion Disease (NIID) with initial presentation mimicking recurrent Transient Global Amnesia (TGA)

    S. Kim, WT. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report an unusual Neuronal intranuclear inclusion disease (NIID) case of a woman who initially presented recurrent Transient Global Amnesia (TGA)…
  • 2023 International Congress

    Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease-related neuropsychiatric symptoms: a Phase 3b study

    G. Alva, W. Cubala, A. Berrio, V. Abler, S. Pathak (Costa Mesa, USA)

    Objective: To evaluate the safety profile of pimavanserin in patients with neuropsychiatric symptoms related to neurodegenerative disease (NDD). Background: Patients with NDD including Parkinson’s disease…
  • 2023 International Congress

    Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

    S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)

    Objective: In the current study, we evaluated a newly developed compound with a 1,3,5-trisubstituted pyrazoline scaffold with an improved PDE5 inhibitory potency as a potential…
  • 2023 International Congress

    Phenotypic characterization of 104 patients with Progressive Supranuclear Palsy: A Tertiary care experience from South India

    R. Yadav, S. Dey, N. Kamble, V. Holla, R. Mahale, M. Debnath, P. Pal (Bangalore, India)

    Objective: To prospectively evaluate and subtype the patients of Progressive supranuclear palsy being referred to a tertiary care movement disorders facility in South India. Background:…
  • 2023 International Congress

    CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.

    J. Bissacco, C. Simonetta, D. Mascioli, N. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To predict long-term clinical outcome of iNPH patients through a panel of neurodegeneration-related CSF biomarkers. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurodegenerative…
  • 2023 International Congress

    Incremental Hospitalizations and Associated Costs of Co-existing Dementia in Patients with Parkinson’s Disease Psychosis: An analysis of US Medicare Beneficiaries

    N. Rashid, K. Rajagopalan, D. Gopal, D. Doshi (San Diego, USA)

    Objective: To evaluate incremental hospitalizations and costs among Medicare patients with Parkinson's disease psychosis (PDP) vs. PDP+dementia (PDP+D). Background: Research examining hospitalizations and costs of…
  • 2023 International Congress

    In vivo positive amyloid PET in a patient with PDD, always reliable?

    S. Enriquez, D. Samaniego, C. Lorenzo-Bosquet, E. Martinez-Saez, A. Garcia-Serra, B. Garcé, S. Belmonte, J. Hernández-Vara (Barcelona, Spain)

    Objective: To describe a singular case of an early-onset Parkinson disease (PD) patient with PD dementia who presented in vivo positive 18 F-Flutebetamol PET but…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley